Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

Share Price is delayed by 15 minutes
Get Live Data
76.70    -1.50 (-1.92%)
Bid:
76.90
Ask:
77.80
Spread: 0.90 (1.17%)
Market Cap: £623.43m
GCP Live PriceLast checked at - London Stock Exchange

Intraday GCP Infrastructure Investments Share Chart

Update research from QuotedData

18 Jan 2022 15:31

RNS Number : 8609Y
GCP Infrastructure Investments Ltd
18 January 2022
 

 

GCP Infrastructure - Update research from QuotedData

18th Jan 2022

 

The future is brighter and greener

 

GCP Infrastructure (GCP) has seen a marked improvement in its net asset value (NAV) performance in recent months. The surge in UK power and carbon prices (see page 8) is working to the benefit of the entities behind many of GCP's renewable energy infrastructure loans.

 

The push to reduce carbon dioxide and other greenhouse gas emissions from the UK economy is likely to provide substantial new opportunities for the company. A £260m pipeline of potential investments identified by the investment adviser is likely to swell over time.

 

Full research:

https://quoteddata.com/research/gcp-infrastructure-future-brighter-greener-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on GCP Infrastructure Investments Limited and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors. 

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGPURPGUPPGAR
Date   Source Headline
27th Apr 20237:00 amRNSNet Asset Value(s)
27th Apr 20237:00 amRNSDividend Declaration
19th Apr 20235:27 pmRNSTransaction in Own Shares
18th Apr 20235:49 pmRNSTransaction in Own Shares
5th Apr 20235:31 pmRNSTransaction in Own Shares
31st Mar 20235:18 pmRNSTotal Voting Rights
30th Mar 20237:00 amRNSDirector Declaration
29th Mar 20235:24 pmRNSTransaction in Own Shares
28th Mar 20234:53 pmRNSTransaction in Own Shares
27th Mar 20234:34 pmRNSTransaction in Own Shares
15th Mar 20235:15 pmRNSTransaction in Own Shares
14th Mar 20235:22 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSShare Buyback Programme Initiated
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Feb 202312:27 pmRNSHolding(s) in Company
15th Feb 202311:42 amRNSResult of AGM
13th Feb 20233:25 pmRNSHolding(s) in Company
7th Feb 20234:52 pmRNSUpdate research from QuotedData
2nd Feb 202310:34 amRNSInvestor Report at 31 December 2022
31st Jan 20233:52 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDividend Declaration
27th Jan 20237:00 amRNSNet Asset Value(s)
12th Jan 20239:55 amRNSNotice of net asset value announcements
11th Jan 20239:15 amRNSDirector Declaration
9th Jan 20239:15 amRNSNotice of AGM
15th Dec 20227:00 amRNSAnnual report and financial statements
28th Oct 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSInvestor Report at 30 September 2022
26th Oct 20227:00 amRNSDividend Declaration
20th Oct 20227:00 amRNSNet Asset Value(s)
30th Sep 202211:13 amRNSResult of EGM
30th Sep 20227:00 amRNSTotal Voting Rights
13th Sep 20225:21 pmRNSNotice of EGM
6th Sep 20229:18 amRNSAdditional Listing and Total Voting Rights
25th Aug 20229:30 amRNSAdditional Listing
11th Aug 20227:00 amRNSScrip Share Reference Price
29th Jul 20227:00 amRNSInvestor Report at 30 June 2022
27th Jul 202212:37 pmRNSResearch from QuotedData
26th Jul 202210:59 amRNSDividend Declaration & Scrip Dividend Alternative
14th Jul 20227:00 amRNSNet Asset Value(s)
30th Jun 20227:00 amRNSTotal Voting Rights
21st Jun 20227:05 amRNSDirectorate Change
21st Jun 20227:00 amRNSHalf-yearly report and financial statements 2022
7th Jun 20229:43 amRNSAdditional Listing and Total Voting Rights
26th May 20229:17 amRNSAdditional Listing
20th May 20223:56 pmRNSHolding(s) in Company
12th May 20227:00 amRNSScrip Share Reference Price
29th Apr 20222:33 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSInvestor Report at 31 March 2022
27th Apr 202211:47 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.